10x Genomics, Inc.
MX ˙ BMV ˙ US88025U1097
SecurityMX:TXG / 10x Genomics, Inc.
InstitutionJasper Ridge Partners, L.P.
Latest Disclosed Ownership39,457 shares
Latest Disclosed Value $ 837,672
Jasper Ridge Partners, L.P. ownership in TXG / 10x Genomics, Inc.

On May 11, 2026 - Jasper Ridge Partners, L.P. filed a 13F-HR form disclosing ownership of 39,457 shares of 10x Genomics, Inc. (MX:TXG) valued at $837,672 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 39,457 shares of 10x Genomics, Inc.. This represents a change in shares of 0.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F 10X GENOMICS CL A COM 88025U109 39,457 0 0.00 838 30.17 0.0186
2026-02-12 2025-12-31 13F 10X GENOMICS CL A COM 88025U109 39,457 0 0.00 644 39.48 0.0143
2025-11-17 2025-09-30 13F 10X GENOMICS CL A COM 88025U109 39,457 0 0.00 461 1.10 0.0104
2025-08-14 2025-06-30 13F 10X GENOMICS CL A COM 88025U109 39,457 0 0.00 457 32.56 0.0114
2025-05-14 2025-03-31 13F 10X GENOMICS CL A COM 88025U109 39,457 0 0.00 344 -39.22 0.0111
2025-02-14 2024-12-31 13F 10X GENOMICS CL A COM 88025U109 39,457 0 0.00 567 -36.40 0.0179
2024-11-14 2024-09-30 13F 10X GENOMICS CL A COM 88025U109 39,457 0 0.00 891 16.04 0.0254
2024-08-14 2024-06-30 13F 10X GENOMICS CL A COM 88025U109 39,457 0 0.00 767 -48.18 0.0248
2024-05-15 2024-03-31 13F 10X GENOMICS CL A COM 88025U109 39,457 0 0.00 1,481 -32.97 0.0466
2024-02-14 2023-12-31 13F 10X GENOMICS CL A COM 88025U109 39,457 0 0.00 2,208 35.71 0.0885
2023-11-14 2023-09-30 13F 10X GENOMICS CL A COM 88025U109 39,457 3,206 8.84 1,628 -19.61 0.0764
2023-08-14 2023-06-30 13F 10X GENOMICS CL A COM 88025U109 36,251 -8,533 -19.05 2,024 -18.98 0.1018
2023-05-15 2023-03-31 13F 10X GENOMICS CL A COM 88025U109 44,784 12,426 38.40 2,498 111.87 0.1191
2023-02-15 2022-12-31 13F 10X GENOMICS CL A COM 88025U109 32,358 0 0.00 1,179 27.87 0.0701
2022-11-14 2022-09-30 13F 10X GENOMICS CL A COM 88025U109 32,358 0 0.00 922 -37.02 0.0618
2022-08-15 2022-06-30 13F 10X GENOMICS CL A COM 88025U109 32,358 3,435 11.88 1,464 -33.45 0.0886
2022-08-15 2022-03-31 13F/A-1 10X GENOMICS CL A COM 88025U109 28,923 3,294 12.85 2,200 -42.38 0.1086
2022-05-13 2022-03-31 13F 10X GENOMICS CL A COM 88025U109 28,923 3,294 2,200 0.1045
2022-08-12 2021-12-31 13F/A-1 10X GENOMICS CL A COM 88025U109 25,629 2,196 9.37 3,818 11.93 0.1432
2022-02-11 2021-12-31 13F 10X GENOMICS CL A COM 88025U109 25,629 2,196 3,818 0.1381
2022-08-12 2021-09-30 13F/A-1 10X GENOMICS CL A COM 88025U109 23,433 0 0.00 3,411 -25.67 0.1520
2021-11-12 2021-09-30 13F 10X GENOMICS CL A COM 88025U109 23,433 0 3,411 0.1467
2022-08-12 2021-06-30 13F/A-2 10X GENOMICS CL A COM 88025U109 23,433 2,544 12.18 4,589 21.37 0.2287
2021-09-10 2021-06-30 13F/A-1 10X GENOMICS CL A COM 88025U109 23,433 2,544 4,589 0.2195
2021-08-12 2021-06-30 13F 10X GENOMICS CL A COM 88025U109 23,433 2,544 4,589 0.2200
2022-08-12 2021-03-31 13F/A-1 10X GENOMICS CL A COM 88025U109 20,889 6,956 49.92 3,781 91.64 0.1739
2021-05-13 2021-03-31 13F 10X GENOMICS CL A COM 88025U109 20,889 6,956 3,781 0.1678
2022-08-12 2020-12-31 13F/A-1 10X GENOMICS CL A COM 88025U109 13,933 200 1.46 1,973 15.25 0.0873
2021-02-12 2020-12-31 13F 10X GENOMICS CL A COM 88025U109 13,933 200 1,973 0.0844
2022-08-12 2020-09-30 13F/A-1 10X GENOMICS CL A COM 88025U109 13,733 6,289 84.48 1,712 157.44 0.0986
2020-11-12 2020-09-30 13F 10X GENOMICS CL A COM 88025U109 13,733 6,289 1,712 0.0941
2022-08-12 2020-06-30 13F/A-1 10X GENOMICS CL A COM 88025U109 7,444 7,444 665 0.0460
2020-08-13 2020-06-30 13F 10X GENOMICS CL A COM 88025U109 7,444 7,444 665 0.0436
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.